SENSEX
NIFTY
GOLD
USD/INR

Weather

image 34    C

Sports News

The Economic Times

Sports / The Economic Times

details

Cipla, China's Qilu partner for US launch of Merck's Keytruda biosimilar

Cipla said its US unit has entered an exclusive partnership with Chinas Qilu Pharmaceutical to license QL2107, a biosimilar of Mercks cancer drug Keytruda. Qilu will handle development, approvals, manufacturing and supply, while Cipla USA will commercialise the treatment in the US, as Cipla expands its oncology biosimilars portfolio.

4 Sep 2026 10:28 am